Alexander Astrakhan

1.0k total citations
18 papers, 759 citations indexed

About

Alexander Astrakhan is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Alexander Astrakhan has authored 18 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Alexander Astrakhan's work include CAR-T cell therapy research (13 papers), Virus-based gene therapy research (7 papers) and Immune Cell Function and Interaction (7 papers). Alexander Astrakhan is often cited by papers focused on CAR-T cell therapy research (13 papers), Virus-based gene therapy research (7 papers) and Immune Cell Function and Interaction (7 papers). Alexander Astrakhan collaborates with scholars based in United States and Belgium. Alexander Astrakhan's co-authors include David J. Rawlings, Jordan Jarjour, Andrew M. Scharenberg, Blythe Sather, Karen Sommer, Malika Hale, Jaya Sahni, Stéphanie Humblet‐Baron, Michael T. Certo and Swati Singh and has published in prestigious journals such as Nucleic Acids Research, Blood and Nature Immunology.

In The Last Decade

Alexander Astrakhan

17 papers receiving 742 citations

Peers

Countries citing papers authored by Alexander Astrakhan

Since Specialization

Citations

This map shows the geographic impact of Alexander Astrakhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Astrakhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Astrakhan more than expected).

Fields of papers citing papers by Alexander Astrakhan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Astrakhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Astrakhan. The network helps show where Alexander Astrakhan may publish in the future.

Co-authorship network of co-authors of Alexander Astrakhan

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Astrakhan. A scholar is included among the top collaborators of Alexander Astrakhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Astrakhan. Alexander Astrakhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Targeting human plasma cells using regulated BCMA CAR T cells eliminates circulating antibodies in humanized mice 2024 ·Molecular Therapy ·Yuchi Honaker, David F. Gruber, (unknown), Rene Yu-Hong Cheng, (unknown), Cristian Galván, Iram Khan, Kelu Zhou, Karen Sommer, Alexander Astrakhan, Peter J. Cook, Richard G. James, David J. Rawlings	0
2	Clinical Translation of SC-DARIC33: A Pharmacologically Controlled CD33-Targeted Anti-AML CAR T Cell Product Regulated By Low Nanomolar Concentrations of Rapamycin 2021 ·Blood ·Jacob Appelbaum, April E. Price, Joy Zhang, (unknown), Sumati Sundaram, Paula Lewis, Sanela Bilic, Giacomo Tampella, (unknown), (unknown), (unknown), Unja Martin, Wai‐Hang Leung, Alexander Astrakhan, Mark Pogson, Jordan Jarjour, Joshua D. Gustafson, Michael C. Jensen	1
3	Sensitive and adaptable pharmacological control of CAR T cells through extracellular receptor dimerization 2019 ·JCI Insight ·(unknown), (unknown), Unja Martin, Tracy E. Garrett, Holly M. Horton, Michael T. Certo, Bruce R. Blazar, Richard A. Morgan, Philip D. Gregory, Jordan Jarjour, Alexander Astrakhan	60
4	Efficient Enrichment of Gene-Modified Primary T Cells via CCR5-Targeted Integration of Mutant Dihydrofolate Reductase 2018 ·Molecular Therapy — Methods & Clinical Development ·(unknown), Guillermo S. Romano Ibarra, Nicholas Hubbard, (unknown), Alexander Astrakhan, David J. Rawlings, Hans‐Peter Kiem, Christopher W. Peterson	7
5	Knockout of CBLB Greatly Enhances Anti-Tumor Activity of CAR T Cells 2018 ·Blood ·(unknown), Kyle Havens, (unknown), Michael S. Magee, Unja Martin, Ankit Gupta, (unknown), (unknown), Amanda J. Rode, (unknown), Shannon Grande, Richard A. Morgan, Jordan Jarjour, Alexander Astrakhan	2
6	Abstract 1536: Enhancing CAR T cell activity by linking IL-12 expression to the endogenous PDCD1 promoter 2018 ·Cancer Research ·(unknown), Wai‐Hang Leung, (unknown), Kyle Havens, (unknown), Richard A. Morgan, Alexander Astrakhan	1
7	Homology-Directed Recombination for Enhanced Engineering of Chimeric Antigen Receptor T Cells 2017 ·Molecular Therapy — Methods & Clinical Development ·Malika Hale, (unknown), Yuchi Honaker, Wai‐Hang Leung, (unknown), Holly M. Jacobs, Karen Sommer, Jaya Sahni, Shaun W. Jackson, Andrew M. Scharenberg, Alexander Astrakhan, David J. Rawlings	58
8	761. Targeted Killing of HIV Infected Cells Using CCR5-Disrupted Anti-HIV-CAR T Cells 2016 ·Molecular Therapy ·Guillermo S. Romano Ibarra, Malika Hale, Karen Sommer, Iram Khan, Jaya Sahni, Christopher W. Peterson, Hans‐Peter Kiem, Jordan Jarjour, Alexander Astrakhan, Andrew M. Scharenberg, David J. Rawlings, Thor A. Wagner	2
9	Efficient Modification of the CCR5 Locus in Primary Human T Cells With megaTAL Nuclease Establishes HIV-1 Resistance 2016 ·Molecular Therapy — Nucleic Acids ·Guillermo S. Romano Ibarra, (unknown), Blythe Sather, Patrick Younan, Karen Sommer, (unknown), Malika Hale, Barry Stoddard, Jordan Jarjour, Alexander Astrakhan, Hans‐Peter Kiem, David J. Rawlings	14
10	Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template 2015 ·Science Translational Medicine ·Blythe Sather, Guillermo S. Romano Ibarra, Karen Sommer, Gabrielle Curinga, Malika Hale, Iram Khan, Swati Singh, Yumei Song, Kamila Gwiazda, Jaya Sahni, Jordan Jarjour, Alexander Astrakhan, Thor A. Wagner, Andrew M. Scharenberg, David J. Rawlings	190
11	megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering 2013 ·Nucleic Acids Research ·(unknown), Jordan Jarjour, Alexander Astrakhan, Andrew C. Adey, Agnès Gouble, Philippe Duchâteau, Jay Shendure, Barry Stoddard, Michael T. Certo, David Baker, Andrew M. Scharenberg	130
12	Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome 2012 ·Blood ·Alexander Astrakhan, Blythe Sather, Byoung Y. Ryu, Socheath Khim, Swati Singh, Stéphanie Humblet‐Baron, Hans D. Ochs, Carol H. Miao, David J. Rawlings	41
13	Development of B-lineage Predominant Lentiviral Vectors for Use in Genetic Therapies for B Cell Disorders 2010 ·Molecular Therapy ·Blythe Sather, Byoung Y. Ryu, Brigid Stirling, (unknown), Hannah M. Kerns, Stéphanie Humblet‐Baron, Alexander Astrakhan, David J. Rawlings	28
14	B cell–specific lentiviral gene therapy leads to sustained B-cell functional recovery in a murine model of X-linked agammaglobulinemia 2010 ·Blood ·Hannah M. Kerns, Byoung Y. Ryu, Brigid Stirling, Blythe Sather, Alexander Astrakhan, Stéphanie Humblet‐Baron, Denny Liggitt, David J. Rawlings	49
15	Antiplatelet antibodies in WASP(−) mice correlate with evidence of increased in vivo platelet consumption 2009 ·Experimental Hematology ·Bindumadhav M. Marathe, (unknown), Alexander Astrakhan, David J. Rawlings, Jim Y. Wan, Ted S. Strom	31
16	Wiskott-Aldrich Syndrome Protein Is Required for Homeostasis and Function of Invariant NKT Cells 2009 ·The Journal of Immunology ·Alexander Astrakhan, Hans D. Ochs, David J. Rawlings	33
17	Local increase in thymic stromal lymphopoietin induces systemic alterations in B cell development 2007 ·Nature Immunology ·Alexander Astrakhan, Miyuki Omori, (unknown), Shirly Becker-Herman, Masanori Iseki, Theingi Aye, Kelly L. Hudkins, James Dooley, Andrew G. Farr, Charles E. Alpers, Steven F. Ziegler, David J. Rawlings	77
18	Sustained correction of B-cell development and function in a murine model of X-linked agammaglobulinemia (XLA) using retroviral-mediated gene transfer 2004 ·Blood ·(unknown), (unknown), R. Kato, Alexander Astrakhan, Stéphanie Humblet‐Baron, (unknown), Keun Chae, Wilfried Ellmeier, Owen N. Witte, David J. Rawlings	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact